Study for the clinical plan of integrated traditional Chinese and conventional medicine in the treatment of pancreatic neoplasm

Not Applicable

Recruiting

• Conditions: pancreatic neoplasm

• Registration Number: ITMCTR1900002287
• Lead Sponsor: Guang'anmen Hospital, China Academy of Chinese Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Female aged 18 to 75 years;
2. Stage III-IV pancreatic cancer patients with definite pathological diagnosis and inoperable operation;
3. expected lifetime>=3 months;
4. The ECOG score is 0-2;
5. Voluntary participation in the study, signing informed consent.

Exclusion Criteria

(1) Patients with serious diseases of heart, liver, kidney and hematopoietic system;
(2) Patients known to be allergic to research medications;
(3) Children, pregnant women, mental patients and patients with other malignant tumors;
(4) Patients undergoing other drug trials.

Study & Design

• Study Type: Observational study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Overall Survival;